KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Retained Earnings (2017 - 2025)

Aquestive Therapeutics has reported Retained Earnings over the past 9 years, most recently at -$447.0 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$447.0 million for Q4 2025, down 23.07% from a year ago — trailing twelve months through Dec 2025 was -$447.0 million (down 23.07% YoY), and the annual figure for FY2025 was -$447.0 million, down 23.07%.
  • Retained Earnings for Q4 2025 was -$447.0 million at Aquestive Therapeutics, down from -$415.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for AQST hit a ceiling of -$200.9 million in Q1 2021 and a floor of -$447.0 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$311.1 million (2022), compared with a mean of -$316.6 million.
  • Biggest five-year swings in Retained Earnings: plummeted 42.83% in 2021 and later decreased 2.53% in 2023.
  • Aquestive Therapeutics' Retained Earnings stood at -$256.8 million in 2021, then dropped by 21.19% to -$311.2 million in 2022, then decreased by 2.53% to -$319.1 million in 2023, then decreased by 13.83% to -$363.2 million in 2024, then dropped by 23.07% to -$447.0 million in 2025.
  • The last three reported values for Retained Earnings were -$447.0 million (Q4 2025), -$415.1 million (Q3 2025), and -$399.7 million (Q2 2025) per Business Quant data.